# About Selank Source: An Independent Research Digest

> Selank Source is an independent editorial project summarizing the peer-reviewed research on Selank. Not a clinic, not a vendor — editorial commentary on publicly available science.

An independent, evidence-first digest of the published Selank literature — and an honest account of its limits.

## What this site is

Selank Source is an independent editorial project that publishes summaries of the peer-reviewed research literature on Selank. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "Source" in the name describes a position relative to the literature — reading the published record at its source and reporting what it says — not a claim to supply, sell, or dispense anything. No product is offered here, and none is endorsed.

## How we read the evidence

Our editorial posture is verification-minded. Where a claim is genuinely measured and cited — the positive allosteric modulation of GABA binding [1], the human-plasma enkephalinase IC50 [2], the rat hippocampal BDNF increase [3], the GABA-pathway gene shift [4], the Russian clinical anxiolytic reports [6] — we report it as such. Where the record is thin, we say so plainly rather than rounding it up.

The honest gap in the Selank literature is stated openly on every relevant page: the great majority of studies come from a small set of Russian research groups, often in Russian-language journals with English abstracts, with limited independent Western replication, and the human pharmacokinetics of the intact peptide are poorly characterized [6]. We treat the cited mechanisms as real and the breadth of human evidence as preliminary.

## What we do not do

We do not recommend doses. We do not tell anyone what to take, and we present the doses and routes from published studies only as descriptions of that research. We do not diagnose or treat anything, and nothing on this site is a substitute for evaluation by a qualified professional. Selank is not approved by the FDA or EMA and, in the United States, is sold only as a research chemical and described here strictly in research contexts [6] — a fact we report rather than promote. We do not name or compare commercial drug brands; we use scientific compound names only.

## Corrections and standards

Every quantitative claim on this site maps to a numbered source in our [Selank references](/references) list, with PubMed IDs and DOIs where available. If a citation is later found to be misattributed or a finding is superseded, our standard is to correct the page rather than leave it standing. The aim is a calm, accurate, well-sourced reading of the Selank record — including the parts of that record that are uncertain.

---

A verification-minded reading of the Selank record — the GABA, enkephalinase and monoamine findings logged to source and tagged by evidence strength, the single-region Russian base and unknown human pharmacokinetics named without flinching; no clinic behind the console, and nothing here dispensed or sold.